HC Wainwright & Co. Reiterates Buy on Zymeworks, Maintains $46 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 91.6%

Neg 0% Neu 91.6% Pos 0%

HC Wainwright & Co. analyst Robert Burns reiterates Zymeworks (NASDAQ:ZYME) with a Buy and maintains $46 price target.

Comments

No comments yet. Be the first!

HC Wainwright &amp; Co. Reiterates Buy on Zymeworks, Maintains $46 Price Target